• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C1q 调节胶原依赖性活性氧的产生、全血中可溶性 P-选择素的聚集和水平。

C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood.

机构信息

Division of Molecular Surface Physics and Nanoscience, Department of Physics, Chemistry and Biology, Linköping University, SE-581 83 Linköping, Sweden.

出版信息

Immunol Lett. 2012 Feb 29;142(1-2):28-33. doi: 10.1016/j.imlet.2011.11.003. Epub 2011 Nov 28.

DOI:10.1016/j.imlet.2011.11.003
PMID:22142906
Abstract

Blood platelets express several receptors involved in immunity (e.g. complement-, toll-like- and Fcγ-receptors) and release inflammatory mediators. Furthermore, formation of platelet-leukocyte aggregates has an important role during inflammatory conditions such as coronary artery disease. Thus, apart from their well-known role in haemostasis, platelets are today also recognized as cells with immuno-modulatory properties. We have previously reported regulatory effects of complement protein 1q (C1q) on platelet activation in experimental setups using isolated cells. In the present study we have proceeded by investigating effects of C1q on collagen-induced aggregation, production of reactive oxygen species (ROS), formation of platelet-leukocyte aggregates and levels of soluble P-selectin in whole blood. Impedance measurements showed that C1q inhibited collagen-induced aggregation whereas it potentiated the collagen-provoked production of ROS in a luminol-dependent chemiluminescence assay. The effects of C1q on aggregation and ROS-production were dependent upon platelets, as they were no longer observed in presence of the platelet (GpIIb/IIIa) inhibitor Reopro. Furthermore, the levels of soluble P-selectin were found to be lowered upon treatment with C1q prior to addition of collagen. There was also a trend towards a decreased formation of large platelet-leukocyte aggregates in collagen-stimulated whole blood following C1q treatment. In conclusion, our data indicate that C1q could have a role in regulating platelet activation and associated leukocyte recruitment during vessel wall injury. This has implications for inflammatory disorders such as coronary artery disease.

摘要

血小板表达几种参与免疫的受体(例如补体、 toll 样和 Fcγ 受体),并释放炎症介质。此外,血小板-白细胞聚集体的形成在炎症状态下(如冠状动脉疾病)具有重要作用。因此,除了在止血方面的众所周知的作用外,血小板现在也被认为具有免疫调节特性的细胞。我们之前已经报道了补体蛋白 1q(C1q)对使用分离细胞的实验设置中的血小板活化的调节作用。在本研究中,我们通过研究 C1q 对胶原诱导的聚集、活性氧物质(ROS)的产生、血小板-白细胞聚集体的形成以及全血中可溶性 P-选择素水平的影响来进行研究。阻抗测量表明 C1q 抑制胶原诱导的聚集,而在发光依赖性化学发光测定中增强胶原引起的 ROS 的产生。C1q 对聚集和 ROS 产生的作用取决于血小板,因为在存在血小板(GpIIb/IIIa)抑制剂 Reopro 的情况下,这些作用不再观察到。此外,在添加胶原之前用 C1q 处理可降低可溶性 P-选择素的水平。胶原刺激的全血中 C1q 处理后,大血小板-白细胞聚集体的形成也呈下降趋势。总之,我们的数据表明 C1q 可能在调节血管壁损伤期间的血小板活化和相关白细胞募集中起作用。这对炎症性疾病(如冠状动脉疾病)有影响。

相似文献

1
C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood.C1q 调节胶原依赖性活性氧的产生、全血中可溶性 P-选择素的聚集和水平。
Immunol Lett. 2012 Feb 29;142(1-2):28-33. doi: 10.1016/j.imlet.2011.11.003. Epub 2011 Nov 28.
2
C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.C1q 诱导人血小板中 P-选择素的快速上调,并调节胶原和胶原相关肽引发的激活。
Immunobiology. 2010 Dec;215(12):987-95. doi: 10.1016/j.imbio.2009.11.004. Epub 2010 Feb 16.
3
Leucocyte activation by collagen-stimulated platelets in whole blood.全血中胶原蛋白刺激的血小板引起的白细胞激活。
Scand J Clin Lab Invest. 2002;62(6):451-61. doi: 10.1080/00365510260390000.
4
Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.硫脂通过P-选择素激活血小板,并增强血小板与血小板-白细胞的聚集。
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):258-63. doi: 10.1161/01.ATV.0000149675.83552.83. Epub 2004 Nov 4.
5
The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.补体因子备解素通过白细胞激活诱导血小板-白细胞聚集体的形成。
Platelets. 2008 Aug;19(5):359-64. doi: 10.1080/09537100802105040.
6
Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation.氯吡格雷抑制血小板与白细胞的黏附以及血小板依赖性白细胞激活。
Thromb Haemost. 2005 Sep;94(3):568-77.
7
Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.氨磷汀是一种具有辐射和化学保护特性的活性氧清除剂,在体外可抑制由二磷酸腺苷(ADP)、胶原蛋白或血小板活化因子(PAF)诱导的血小板活化。
Haematologica. 2000 Aug;85(8):820-5.
8
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.在存在糖蛋白IIb/IIIa拮抗剂的情况下,血小板-白细胞结合物上P-选择素、组织因子和CD40配体的表达
Platelets. 2003 Nov-Dec;14(7-8):473-80. doi: 10.1080/09537100310001638562.
9
Free platelet count and size distribution during C1q inhibition of collagen-induced platelet aggregation.
Thromb Haemost. 1987 Aug 4;58(2):682-5.
10
Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates.血小板P-选择素通过形成大量稳定的血小板-白细胞聚集体在动脉血栓形成中起重要作用。
J Am Coll Cardiol. 2005 Apr 19;45(8):1280-6. doi: 10.1016/j.jacc.2004.12.071.

引用本文的文献

1
The Role of Thrombo-inflammation in Ischemic Stroke: Focus on the Manipulation and Clinical Application.血栓炎症在缺血性卒中中的作用:聚焦于调控与临床应用
Mol Neurobiol. 2025 Feb;62(2):2362-2375. doi: 10.1007/s12035-024-04397-w. Epub 2024 Aug 6.
2
Unraveling the Intricate Web: Complement Activation Shapes the Pathogenesis of Sepsis-Induced Coagulopathy.解开复杂的谜团:补体激活塑造了脓毒症诱导的凝血障碍的发病机制。
J Innate Immun. 2024;16(1):337-353. doi: 10.1159/000539502. Epub 2024 May 31.
3
ITGB2 is a central hub-gene associated with inflammation and early fibro-atheroma development in a swine model of atherosclerosis.
整合素β2(ITGB2)是在动脉粥样硬化猪模型中与炎症和早期纤维粥样瘤发展相关的一个核心枢纽基因。
Atheroscler Plus. 2023 Nov 15;54:30-41. doi: 10.1016/j.athplu.2023.11.001. eCollection 2023 Dec.
4
Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.急诊经皮冠状动脉介入治疗患者血清补体C1q水平与造影剂相关急性肾损伤有关。
J Inflamm Res. 2021 Dec 24;14:7331-7339. doi: 10.2147/JIR.S343715. eCollection 2021.
5
Serum Complement C1q Activity Is Associated With Obstructive Coronary Artery Disease.血清补体C1q活性与阻塞性冠状动脉疾病相关。
Front Cardiovasc Med. 2021 Apr 29;8:618173. doi: 10.3389/fcvm.2021.618173. eCollection 2021.
6
Early pathological characterization of murine dissecting abdominal aortic aneurysms.小鼠夹层腹主动脉瘤的早期病理学特征
APL Bioeng. 2018 Dec 20;2(4):046106. doi: 10.1063/1.5053708. eCollection 2018 Dec.
7
Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.THPDTPI的对接:探索P-选择素作为抗肿瘤、抗血栓形成和抗炎药物的共同靶点。
Oncotarget. 2017 Jul 19;9(1):268-281. doi: 10.18632/oncotarget.19374. eCollection 2018 Jan 2.
8
Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.小分子PZL318:形成能够追踪其与癌细胞和活化血小板相互作用的荧光纳米颗粒,减缓肿瘤生长并抑制血栓形成。
Int J Nanomedicine. 2015 Aug 24;10:5273-92. doi: 10.2147/IJN.S88052. eCollection 2015.